# Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

> **NCT06933329** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **BicycleTx Limited** · enrollment: 73 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Zelenectide pevedotin

## Key facts

- **NCT ID:** NCT06933329
- **Lead sponsor:** BicycleTx Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-18
- **Primary completion:** 2028-08-31
- **Final completion:** 2029-02-28
- **Target enrollment:** 73 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06933329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06933329, "Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06933329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*